Emergent BioSolutions (EBS) Tops Q1 EPS by 23c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.49 -1.32%
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.16, $0.23 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $111 million versus the consensus estimate of $101.83 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emergent BioSolutions (EBS) PT Lowered to $10 at H.C. Wainwright
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
